Definition of Ischemic Cardiomyopathy
Ischemic cardiomyopathy is left ventricular systolic dysfunction (ejection fraction ≤40%) caused by significant coronary artery disease, representing the most common cause of heart failure in developed countries 1.
Core Diagnostic Criteria
The definition requires two essential components:
- Significant left ventricular dysfunction: Ejection fraction <40% 1
- Documented coronary artery disease: Angiographically confirmed epicardial coronary disease 2, 3
Pathophysiological Substrate
Ischemic cardiomyopathy results from loss of myocytes due to myocardial necrosis in coronary artery disease, which remains the leading cause of heart failure 4. The condition encompasses several distinct but overlapping pathophysiological states:
Mechanisms of Myocardial Dysfunction
- Irreversible myocardial necrosis and infarction: From prolonged severe ischemia causing permanent myocyte loss 4
- Myocardial stunning: Sub-acute left ventricular dysfunction persisting after acute ischemia when reperfusion has occurred 4
- Hibernating myocardium: Advanced ischemic dysfunction from repeated stunning episodes or chronic low flow, characterized by myocellular dedifferentiation with loss of contractile proteins and altered metabolism 4
- Ventricular remodeling: Expansion of necrotic areas and hypertrophy-dilatation of remaining viable myocardium, eventually leading to heart failure 5
Important Clinical Distinctions
Coronary Disease Extent Matters Prognostically
Patients with single-vessel disease and no prior myocardial infarction or revascularization should be classified as nonischemic for prognostic purposes 3. This modified classification provides superior prognostic power compared to traditional definitions. More extensive coronary disease is independently associated with shorter survival 3.
Mixed Pathophysiology
A critical caveat: These pathophysiological states rarely exist in pure form but often coexist and overlap in individual patients, with areas of irreversible scar and viable tissue frequently mixed 4. Additional factors contributing to dysfunction include:
- Stretch from global left ventricular remodeling 4
- Regional tethering from adjacent scarred regions 4
- Electromechanical dyssynchrony with bundle branch block 4
- Superimposed non-ischemic causes (inflammation, genetic, metabolic, or toxic etiologies) 4
Differentiation from Non-Ischemic Cardiomyopathy
The cause of cardiomyopathy may be ischemia or infarction based on coronary artery disease, or nonischemic as a result of genetic or acquired defects of myocardial cell structure or metabolism 6. While both ischemic and nonischemic dilated cardiomyopathies develop similar heart failure symptoms and carry increased risk for premature death 1, the ischemic etiology is specifically defined by the presence of significant coronary disease.
Clinical Significance
Ischemic cardiomyopathy represents a major public health burden with 1-year mortality of 16% and 5-year mortality of approximately 40% in the USA and Europe 7. The prognosis is primarily related to the degree of ventricular dysfunction and extent of coronary artery disease 8.